Tirzepatide has been associated with a small increased risk of thyroid C-cell tumors in rodents, though its relevance to humans remains unclear
Always consult with healthcare providers to ensure a personalized and effective treatment plan
141(3):e39-53
Samson, MD, PhD, FRCPC, FACE, Mayo Clinic, Jacksonville, Florida research support, steering committee, and national or overall principal investigator: Chiasma, Novartis Carla Stec, MA, American Association of Clinical Endocrinology, Jacksonville, FL reports no potential conflicts of interest William V
Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in hiv-1-infected patients